What is the treatment for akathisia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Akathisia Treatment

Propranolol 10-30mg two to three times daily is the first-line treatment for akathisia, with evidence supporting its efficacy over other agents. 1

First-line Approaches

Medication Adjustments

  1. Modify the causative antipsychotic:
    • Lower the dosage of the causative antipsychotic medication 1
    • Switch to an antipsychotic with lower risk of akathisia (e.g., quetiapine) 1
    • Initial quetiapine dosing: 12.5mg twice daily; maximum: 200mg twice daily 1

Pharmacological Interventions

  1. Beta-blockers:

    • Propranolol 10-30mg two to three times daily 1
    • Use with caution in patients with asthma, diabetes, or cardiovascular disease 1
    • Most consistently effective treatment for acute akathisia 2
  2. Benzodiazepines:

    • Lorazepam 0.5-2mg as needed 1
    • Note: Regular use can lead to tolerance and dependence 1
  3. Anticholinergics:

    • Benztropine 1-4mg once or twice daily 3
    • For drug-induced extrapyramidal disorders: 1-2mg twice daily 3
    • Maximum daily dose: 6mg 3
    • Particularly useful for acute dystonic reactions 3

Second-line Treatments

  1. 5-HT2A antagonists:

    • Mirtazapine (7.5-15mg once daily) has shown compelling evidence for efficacy 4
    • Recent evidence suggests mirtazapine may be more effective than propranolol (SMD -1.20 vs -0.78) 5
    • Other options include trazodone (50mg daily) and mianserin (15mg daily) 5
  2. Other options:

    • Vitamin B6 (600-1200mg daily) has shown good efficacy and tolerance profile 5
    • Biperiden (6mg daily) has demonstrated efficacy 5
    • Amantadine or clonidine may be tried if other treatments fail 2

Treatment Algorithm

  1. Initial assessment:

    • Use a validated scale (e.g., Abnormal Involuntary Movement Scale) to assess severity 1
    • Identify the causative medication
  2. First steps:

    • Reduce dose of causative antipsychotic if clinically feasible 1
    • Consider switching to an antipsychotic with lower akathisia risk (e.g., quetiapine) 1
  3. Adjunctive medication (if step 1 insufficient):

    • Start propranolol 10mg BID-TID (if no contraindications) 1
    • If propranolol contraindicated or ineffective, try benzodiazepines 1, 2
    • If still ineffective, consider mirtazapine 15mg daily 4, 5
  4. Monitoring:

    • Regular assessment for abnormal movements 1
    • Monitor for medication-specific side effects (e.g., orthostatic hypotension with propranolol) 1

Special Considerations

  • Elderly patients: Use lower doses due to increased sensitivity to CNS effects 1
  • Patients with Parkinson's disease: Extremely sensitive to antipsychotic effects; consider pimavanserin, clozapine, or quetiapine 1
  • Cardiovascular disease: Monitor for orthostatic hypotension, especially with propranolol 1
  • Pregnancy: Avoid combination therapy with valproate and risperidone 1

Important Caveats

  • Abrupt withdrawal of antipsychotics can worsen symptoms; changes should be gradual 1
  • Second-generation (atypical) antipsychotics generally have lower risk of akathisia than first-generation agents 1
  • Akathisia can significantly impact treatment adherence and quality of life 1, 2
  • Evidence for tardive akathisia treatment is limited compared to acute akathisia 2

The most recent and comprehensive evidence from a 2024 network meta-analysis suggests mirtazapine, biperiden, and vitamin B6 may be more effective than propranolol for antipsychotic-induced akathisia 5, but clinical guidelines still recommend propranolol as first-line therapy 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.